Labcorp Drug Development Inc. · Indianapolis, Indiana
Case #I-200-21194-459124
A Validation Engineer III position at Labcorp Drug Development Inc. in Indianapolis, Indiana was filed at $80k per year, offering 0% above the prevailing wage of $80k. The case was processed in 0 days during the FY FY2021 cycle. This position is for continued employment.
| Case Number | I-200-21194-459124 |
| Case Status | Withdrawn |
| Visa Class | H-1B |
| Fiscal Year | FY 2021 |
| Employer | Labcorp Drug Development Inc. |
| Employer Location | Princeton, New Jersey |
| Job Title | Validation Engineer III |
| SOC Code | 15-119900 – Computer Occupations, All Other |
| Worksite | Indianapolis, Indiana |
| Annual Wage | $80k – $90k |
| Prevailing Wage | $80k |
| Wage Premium | 0.0% |
| Positions | 1 (0 new, 0 continued) |
| Job Title | Salary | Status | Date |
|---|---|---|---|
| Staff Scientist I | $66k | CERTIFIED | Apr 27, 2023 |
| Principal Programmer | $127k | CERTIFIED | Apr 25, 2023 |
| Enterprise Workforce Lead | $116k | CERTIFIED | Apr 20, 2023 |
| Sr. Manager Financial Analysis | $96k | CERTIFIED | Apr 14, 2023 |
| Senior Statistical Programmer | $114k | CERTIFIED | Apr 11, 2023 |
This Labor Condition Application (LCA) was filed by Labcorp Drug Development Inc. for the position of Validation Engineer III in Indianapolis, Indiana. The offered annual salary is $80k, compared to the prevailing wage of $80k for this occupation and location. This represents a wage premium of 0.0% above the prevailing wage.
The LCA is the first step in the H-1B visa process. Employers must file an LCA with the Department of Labor certifying that they will pay the foreign worker at least the prevailing wage for the occupation in the area of intended employment. A certified LCA is required before the employer can file an H-1B petition with USCIS.
Case status: Withdrawn. This means the employer or their representative withdrew the application.
A Labor Condition Application (LCA) is a mandatory document that U.S. employers must file with the U.S. Department of Labor (DOL) before they can petition for a foreign worker under the H-1B, H-1B1, or E-3 visa categories. The LCA process was established under the Immigration and Nationality Act (INA) to protect both foreign and domestic workers by ensuring fair wages and working conditions.
When a U.S. company identifies a foreign national to fill a specialty occupation position, they must first obtain DOL certification through the LCA process before filing the H-1B petition (Form I-129) with U.S. Citizenship and Immigration Services (USCIS). In this case, Labcorp Drug Development Inc. filed LCA case number I-200-21194-459124 to sponsor a Validation Engineer III position at their worksite in Indianapolis, Indiana. By filing this LCA, the employer attests to four key conditions: (1) paying the higher of the actual wage or prevailing wage, (2) providing working conditions that will not adversely affect other similarly employed workers, (3) no strike or lockout at the worksite, and (4) providing notice of the filing to the bargaining representative or posting notice at the worksite.
The DOL establishes four wage levels for each occupation and geographic area, representing the progression from entry-level to fully competent workers:
For this filing, the offered wage of $80k compares to the DOL prevailing wage of $80k for Computer Occupations, All Other positions in the Indianapolis, Indiana area. The positive wage premium of 0.0% indicates the employer is offering above the DOL-determined average for this occupation and location.
The prevailing wage is the average wage paid to similarly employed workers in a specific occupation in the area of intended employment. The DOL determines prevailing wages using data from the Occupational Employment and Wage Statistics (OEWS) survey conducted by the Bureau of Labor Statistics (BLS). Employers must pay H-1B workers the higher of the prevailing wage or the actual wage paid to other employees in similar positions at the company. This requirement is designed to prevent employers from using H-1B workers to undercut domestic wages.
A "Certified-Withdrawn" status means this LCA was initially certified by the DOL but was later withdrawn by the employer. This can happen for various reasons: the foreign worker may have declined the position, found employment elsewhere, the employer may have decided to refile with updated information, or business conditions may have changed. A withdrawal does not negatively affect the employer's ability to file future LCAs.
The offered salary of $80k for this Validation Engineer III position provides a data point for evaluating compensation trends in H-1B visa sponsorship. When reviewing H-1B salary data, consider that wages vary significantly based on geographic location, employer size, industry sector, and the worker's experience level. This position falls under SOC code 15-119900 (Computer Occupations, All Other), which standardizes how the Bureau of Labor Statistics classifies occupations across industries. Metropolitan areas like New York, San Francisco, and Seattle typically command higher salaries due to higher costs of living, while positions in smaller markets may offer lower nominal wages but comparable purchasing power.
The offered annual salary for this Validation Engineer III position at Labcorp Drug Development Inc. is $80k to $90k. The Department of Labor prevailing wage for this occupation and location is $80k. The offered wage represents a 0.0% premium over the prevailing wage.
This H-1B filing is for a position located in Indianapolis, Indiana. The employing company, Labcorp Drug Development Inc., is headquartered in Princeton, New Jersey.
This Labor Condition Application is filed under the H-1B visa classification. The H-1B visa is designed for specialty occupation workers who possess at least a bachelor's degree or equivalent in a specific field related to the job.
The employer for this filing is Labcorp Drug Development Inc., located in Princeton, New Jersey. Labcorp Drug Development Inc. filed this Labor Condition Application (case number I-200-21194-459124) for a Validation Engineer III position during fiscal year FY 2021. View all Labcorp Drug Development Inc. H-1B filings.
Certified-Withdrawn means this LCA was initially certified by the DOL but was subsequently withdrawn by the employer or their authorized representative.